Tag: peptide identity verification
Quick answer: All three were pharmaceutical programs, not community discoveries. One completed Phase 2 trials with positive results and then ran out of company. One failed its pivotal trial outright and was abandoned in 2007. One spent two decades missing endpoints and then won an FDA approval in 2025. Knowing which is which tells you […]
Quick answer: These three names get used interchangeably across the peptide market, and they should not be. Thymosin alpha-1 is a 28-amino-acid synthetic peptide. Thymulin is a 9-amino-acid synthetic peptide requiring zinc for activity. Thymalin is not a single peptide at all - it is a polypeptide complex extracted from calf thymus. Two […]
Quick answer: Both were recommended by the FDA’s advisory committee in July 2026, and both received a fraction of the coverage that BPC-157 and TB-500 did. They also share something more interesting than a vote: nearly their entire published record comes from a single national research tradition, which is exactly the criticism FDA staff raised […]